XML 31 R18.htm IDEA: XBRL DOCUMENT
v3.25.3

Equity and Net Income Per Common Share | 9 Months Ended
--- | ---
Sep. 30, 2025
Equity and Net Income Per Common Share |
Equity and Net Income Per Common Share | (11) Equity and Net Income Per Common Share
(a) | Preferred Stock
The Board authorized 100,000,000 shares of preferred stock on March 12, 2019, and issued 10,000 shares of preferred stock designated as "5.5% Series A Non-Voting Perpetual Preferred Stock" (the "Series A Preferred Stock"), to The Antero Foundation on that date. Dividends on the Series A Preferred Stock are cumulative from the date of original issue and payable in cash on the 45th day following the end of each fiscal quarter, or such other dates as the Board will approve, at a rate of 5.5% per annum on (i) the liquidation preference per share of Series A Preferred Stock (as described below) and (ii) the amount of accrued and unpaid dividends for any prior dividend period on such share of Series A Preferred Stock, if any. At any time following the date of issue, in the event of a change of control, or at any time on or after March 12, 2029, the Company may redeem the Series A Preferred Stock at a price equal to $1,000 per share, plus any accrued and unpaid dividends, payable in cash; provided that if any shares of the Series A Preferred Stock are held by The Antero Foundation at the time of such redemption, the price for redemption of each share of Series A Preferred Stock will be the greater of (i) $1,000 per share, plus any accrued but unpaid dividends, and (ii) the fair market value of the Series A Preferred Stock. On or after March 12, 2029, the holder of each share of Series A Preferred Stock (other than The Antero Foundation) may convert such shares, at any time and from time to time, at the option of the holder into a number of shares of the Company’s common stock equal to the conversion ratio in effect on the applicable conversion date, subject to certain limitations. The Series A Preferred Stock ranks senior to the Company’s common stock as to dividend rights, as well as with respect to rights upon liquidation, winding-up or dissolution of the Company. Holders of the Series A Preferred Stock do not have any voting rights in the Company, except as required by law, or any preemptive rights.
(b) | Weighted Average Common Shares Outstanding
The following is a reconciliation of the Company’s basic weighted average common shares outstanding to diluted weighted average common shares outstanding: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, | ​ | Nine Months Ended September 30, | ​
(in thousands) |  | 2024 | ​ | 2025 |  | 2024 | ​ | 2025 | ​
Basic weighted average number of common shares outstanding | ​ | ​ | 481,288 | ​ | ​ | 478,020 | ​ | ​ | 480,765 | ​ | ​ | 478,719 | ​
Add: Dilutive effect of RSUs | ​ | ​ | 2,056 | ​ | ​ | 1,781 | ​ | ​ | 2,180 | ​ | ​ | 2,129 | ​
Add: Dilutive effect of PSUs | ​ | ​ | 1,524 | ​ | ​ | 1,499 | ​ | ​ | 1,301 | ​ | ​ | 1,505 | ​
Add: Dilutive effect of Series A Preferred Stock | ​ | ​ | 664 | ​ | ​ | 514 | ​ | ​ | 664 | ​ | ​ | 514 | ​
Diluted weighted average number of common shares outstanding | ​ | ​ | 485,532 | ​ | ​ | 481,814 | ​ | ​ | 484,910 | ​ | ​ | 482,867 | ​
​ There were no anti-dilutive securities outstanding during the three and nine months ended September 30, 2024 and 2025.
(c) | Net Income Per Common Share
Net income per common share—basic for each period is computed by dividing the net income or loss attributable to the Company by the basic weighted average number of common shares outstanding during the period. Net income per common share—diluted for each period is computed after giving consideration to the potential dilution from outstanding equity-based awards, calculated using the treasury stock method. During periods in which the Company incurs a net loss, diluted weighted average common shares outstanding are equal to basic weighted average common shares outstanding because the effect of all equity-based awards is anti-dilutive. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, | ​ | Nine Months Ended September 30, | ​
(in thousands, except per share amounts) |  | 2024 | ​ | 2025 |  | 2024 | ​ | 2025 | ​
Net income | ​ | $ | 99,740 | ​ | ​ | 115,984 | ​ | ​ | 289,703 | ​ | ​ | 361,234 | ​
Less preferred stock dividends | ​ | ​ | (138) | ​ | ​ | (138) | ​ | ​ | (413) | ​ | ​ | (413) | ​
Net income available to common shareholders | ​ | $ | 99,602 | ​ | ​ | 115,846 | ​ | ​ | 289,290 | ​ | ​ | 360,821 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income per common share–basic | ​ | $ | 0.21 | ​ | ​ | 0.24 | ​ | ​ | 0.60 | ​ | ​ | 0.75 | ​
Net income per common share–diluted | ​ | $ | 0.21 | ​ | ​ | 0.24 | ​ | ​ | 0.60 | ​ | ​ | 0.75 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Weighted average common shares outstanding–basic | ​ | ​ | 481,288 | ​ | ​ | 478,020 | ​ | ​ | 480,765 | ​ | ​ | 478,719 | ​
Weighted average common shares outstanding–diluted | ​ | ​ | 485,532 | ​ | ​ | 481,814 | ​ | ​ | 484,910 | ​ | ​ | 482,867 | ​
​

X
- Definition N/A + References No definition available. + Details
Name: | am_EquityAndEarningsPerCommonShareAbstract
Namespace Prefix: | am_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of equity and earnings per share. + References No definition available. + Details
Name: | am_EquityAndEarningsPerCommonShareTextBlock
Namespace Prefix: | am_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration